Considerations for assessing the potential effects of antidiabetes drugs on cardiac ventricular repolarization: A report from the Cardiac Safety Research Consortium

View Paper Here

Simon Heller, FRCP,  Börje Darpö, MD, PhD,  Malcolm I. Mitchell, MBBS, MFPM, Helle Linnebjerg, PhD, Derek J. Leishman, PhD, DSP,  Nitin Mehrotra, PhD,  Hao Zhu, PhD,  John Koerner, PhD,  Mónica L. Fiszman, MD, PhD,  Suchitra Balakrishnan, MD, PhD,  Shen Xiao, MD, PhD,  Thomas G. Todaro, MD, JD,  Ingrid Hensley, PhD,  Brian D. Guth, PhD,  Eric L. Michelson, MD, FACC, and Philip Sager, MD, FACC, FAHA, FHRS  Sheffield,United Kingdom; Stockholm, Sweden; Rochester, NY; Indianapolis, IN; Silver Spring, MD; Cincinnati, OH; Biberach an der Riss, Germany; Philadelphia, PA; and Stanford, CA